Hyperglycemic Hyperosmolar Syndrome in Children: Pathophysiological Considerations and Suggested Guidelines for Treatment - 02/08/11
, Andrea Haqq, MD b, Arlan Rosenbloom, MD c, Nicole Glaser, MD dfor the Drugs and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society![]()
Mots-clés : CE, DKA, HHS
Plan
| A.H. received support from the Alberta Diabetes Institute and the Women & Children's Health Research Institute at University of Alberta. These Clinical Practice Guideline are endorsed by the Lawson Wilkins Pediatric Endocrine Society. They were developed to be of assistance to endocrinologists by providing guidance and recommendations for particular areas of practice. The Guidelines should not be considered inclusive of all proper approaches or methods, or exclusive of others. They do not guarantee any specific outcome, nor do they establish a standard of care. The Guidelines are not intended to dictate the treatment of a particular patient. Treatment decisions must be made based on the independent judgment of healthcare providers and each patient's individual circumstances. The authors declare no conflicts of interest. |
Vol 158 - N° 1
P. 9 - janvier 2011 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
